Antibody response of COVID-19 patients to SARS-CoV-2 and seasonal coronaviruses 11/03/2021 Health News, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, in 2019....
Antibody kinetics after natural SARS-CoV-2 infection and COVID-19 vaccination in Hispanic/Latino population 10/04/2021 Health News, The coronavirus disease 19 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2...
Is COVID-19 a new disease? 05/10/2021 Health News, In a review recently published in The Lancet Respiratory Medicine journal by Osuchowski et al....
Measurable antibody response to mRNA COVID-19 vaccine in elderly care home residents 04/13/2021 Health News, The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2...
Breath Analysis: How Could it Improve Healthcare and Diagnosis? 04/08/2021 Health News, insights from industrySanti Dominguez & Michael GrazCEO & Acting CEOImspex Diagnostics & Imspex MedicalIn this...
Study suggests T-cells don't determine survival in severe COVID-19 04/06/2021 Health News, The coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes...
Obesity may reduce COVID-19 vaccine efficacy, say researchers 03/03/2021 Health News, A startling new study by researchers at the Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy, indicates...
UIC researchers receive $10.15 million grant to develop treatment for dry eye conditions 02/10/2021 Health News, Researchers at University of Illinois Chicago have been awarded a five-year, $10.15 million grant to...
Antibody testing likely undercounts past covid infections by 28% 11/25/2020 Health News, Antibody testing likely undercounts the number of people who have had COVID-19: More than 25%...
Regeneron’s Casirivimab and Imdevimab Antibody Cocktail for COVID-19 is First Combination Therapy to Receive FDA Emergency Use Authorization 11/23/2020 Medications, TARRYTOWN, N.Y., November 21, 2020 – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the antibody...